Viberzi Coupons & Savings Card – Discount Prices from $839.81
My prescription
Edit
100MG, Viberzi (30 Tablets)
Select pharmacy
CVS
$839.81
COUPON PRICE
Albertsons
$856.90
COUPON PRICE
Walgreens
$864.62
COUPON PRICEViberzi savings card
Show this card to your pharmacistCVS
$839.81
BIN
ID
PCN
GRP
019876
LH73ACAFC0
CHIPPO
LHX
Powered by
Related opioid agonist/antagonists prescriptions
More prescriptions for irritable bowel syndrome
Related opioid agonist/antagonists prescriptions
More prescriptions for irritable bowel syndrome
Price history for Viberzi
30 Tablets, 100MG
Average retail price for Viberzi
Average SaveHealth price for Viberzi
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Viberzi dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 75MG | 30 Tablets | $839.81 | $27.99 |
| 100MG | 30 Tablets | $839.81 | $27.99 |
Viberzi Warnings
This safety information highlights important warnings related to the use of Viberzi (eluxadoline). Please read it carefully and consult your healthcare provider if you have any questions or concerns.
Pancreatitis Risk: Viberzi (eluxadoline) has been associated with cases of pancreatitis, a serious condition involving inflammation of the pancreas. This risk is particularly elevated in individuals without a gallbladder and those consuming more than three alcoholic beverages daily. Symptoms typically appear within the first week of treatment and include severe abdominal pain that may radiate to the back or shoulders, possibly accompanied by nausea and vomiting. If you experience these symptoms, discontinue the medication immediately and seek medical advice.
Constipation: Use of Viberzi (eluxadoline) may lead to constipation, which in some instances can result in significant complications necessitating medical intervention. Should you experience constipation while on this medication, stop using it and contact your healthcare provider.
Allergic Reactions: There is a potential for allergic reactions in some individuals taking Viberzi (eluxadoline), which may occur shortly after the initial doses. Symptoms can include difficulty breathing, facial or throat swelling, and chest pain or tightness. If you experience any of these symptoms, discontinue use immediately and contact your healthcare provider.
Please note that there are no specific contraindications listed for Viberzi (eluxadoline) in the provided information. Always seek guidance from your healthcare provider before making any changes to your medication regimen.
Viberzi Side Effects
When taking this medication, some individuals may experience mild side effects such as constipation, nausea, or abdominal pain. These effects are generally not severe, but if they persist or worsen, please consult your healthcare provider for advice. Other less common side effects include symptoms similar to a common cold (such as a runny nose and cough), vomiting, bloating, dizziness, gas, and rash. While most side effects are not serious, there are rare instances of severe reactions. These include signs of pancreatitis, characterized by severe abdominal pain that may radiate to the back or shoulder, which requires immediate medical attention. Additionally, a very serious allergic reaction to this drug is rare but possible. If you experience symptoms such as a rash, itching or swelling (especially of the face, tongue, or throat), severe dizziness, or difficulty breathing, seek emergency medical help immediately. It is important to note that many people taking this medication do not experience severe side effects. However, always remain vigilant and contact your healthcare provider if you notice any concerning symptoms. Remember that the list above is not exhaustive, and any unexpected effects should be discussed with a healthcare professional.
Viberzi Interactions
When taking Viberzi (eluxadoline) for irritable bowel syndrome with diarrhea (IBS-D), it's important to be aware of potential interactions with other medications and substances:
Medications That May Increase Eluxadoline Levels:
- OATP1B1 Inhibitors: Drugs like Cyclosporine, Gemfibrozil, certain antiretrovirals (e.g., Atazanavir, lopinavir, Ritonavir, saquinavir, tipranavir), Rifampin, and eltrombopag can raise eluxadoline levels in your body. If you're taking any of these, your doctor may adjust your Viberzi dose to 75 mg twice daily and monitor you for side effects.
Medications That May Increase the Risk of Constipation:
- Constipating Agents: Combining Viberzi with medications that can cause constipation, such as Alosetron, anticholinergics (used for conditions like overactive bladder or motion sickness), and opioids, may heighten the risk of constipation-related side effects. It's advisable to avoid using these drugs together. If you need to use Loperamide occasionally for severe diarrhea, do so cautiously and discontinue it immediately if constipation occurs.
Medications That May Be Affected by Eluxadoline:
- OATP1B1 and BCRP Substrates: Viberzi may increase the levels of drugs transported by OATP1B1 and BCRP proteins, such as Rosuvastatin. This could raise the risk of muscle-related side effects. If you're on rosuvastatin, your doctor might recommend the lowest effective dose.
Alcohol Consumption:
- Alcohol: Drinking more than three alcoholic beverages per day while on Viberzi can increase the risk of pancreatitis, a serious inflammation of the pancreas. It's best to limit alcohol intake during treatment.
Always inform your healthcare provider about all medications, supplements, and substances you're using to ensure safe and effective treatment with Viberzi.
Why is Viberzi considered a narcotic?
Viberzi is considered a narcotic because it acts on the opioid receptors in the body. It is classified as a Schedule IV controlled substance due to its potential for abuse and dependence, similar to other narcotics.
Is Viberzi the same as Imodium?
Viberzi and Imodium are not the same. Viberzi (eluxadoline) is a prescription medication used to treat irritable bowel syndrome with diarrhea (IBS-D), while Imodium (loperamide) is an over-the-counter medication used to treat diarrhea by slowing down gut movement. They work differently and are used for different purposes.
How does Viberzi work in the body?
Viberzi works by targeting the digestive system, specifically the gut. It acts as a mu-opioid receptor agonist and a delta-opioid receptor antagonist. This dual action helps to reduce bowel contractions and slow down the movement of the intestines, which can alleviate symptoms such as diarrhea and abdominal pain associated with irritable bowel syndrome with diarrhea (IBS-D).
Is Viberzi habit forming?
Viberzi (eluxadoline) is not considered habit-forming. It is a medication used to treat irritable bowel syndrome with diarrhea (IBS-D) and does not have addictive properties. However, it is important for patients to use it as prescribed by their healthcare provider.
What makes Viberzi a controlled substance?
Viberzi (eluxadoline) is classified as a controlled substance because it acts on the opioid receptors in the body. This action has the potential for abuse and dependence, similar to other opioid medications. Therefore, it is regulated to prevent misuse and ensure safe prescribing practices.